Healthcare Workers Trained
FY, 2021
New Phase I Projects
Q2, 2022
New Phase II Projects
Q2, 2022
Metrics | FY, 2019 | FY, 2020 | FY, 2021 |
---|---|---|---|
Healthcare Workers Trained | 81.6K | 132.2K | 199K |
New Phase I Projects | 5 | 5 | 5 |
New Phase II Projects | 5 | 8 | 2 |
People Reached (Patient Assistance Programmes) | 9.7M | 10.1M | 11M |
NME Phase I | 32 | 27 | |
LCM in Late-stage Development (BioPharmaceuticals) | 9 | 9 | 14 |
LCM Phase II (BioPharmaceuticals) | 1 | 3 | 5 |
LCM in Late-stage Development (Oncology) | 20 | 30 | 32 |
LCM Phase II (Oncology) | 2 | 8 | 7 |
LCM Phase I (Oncology) | 1 | 1 | 1 |
NME Phase II | 39 | 36 | 32 |
NME in Late-stage Development | 8 | 10 | 15 |
Projects in R&D Pipeline | 167 | 171 | 177 |
Countries | 100 | 100 | 130 |
Scientific Collaborations | 730 | 800 | 1K |
Health Facilities Activated | 2.6K | 3.4K | |
Phase I Trials Projects | 34 | 35 | 32 |
Phase II Trials Projects | 50 | 42 | 34 |
Phase III Trials Projects | 27 | 25 | 32 |
Young Health Programme Members | 4M | ||
NME Phase I (Oncology) | 18 | 21 | 15 |
NME Phase II (Oncology) | 27 | 21 | 17 |
NME in Late-stage Development (Oncology) | 12 | 10 | 15 |
NME Phase I (Biopharmaceuticals) | 16 | 14 | 14 |
NME Phase II (Biopharmaceuticals) | 22 | 21 | 15 |
NME in Late-stage Development (Biopharmaceuticals) | 5 | 5 | 5 |
Blood Pressure Screenings (Africa) | 13.5M | 16.7M | 23M |
Life-cycle Management Projects | 56 | 69 | 79 |
People Reached (Healthcare Programmes) | 16.4M | 25M | 31M |
New Pivotal Study Projects | 8 | 7 | |
New Projects to Registration | 2 | 6 |
Community
Employees
Environment
Governance
Source:CSRHub
Ads
Analytics
CDN
Cdn
Cdns
Cms
Copyright
Css
Feeds
Framework
Hosting
Javascript